Dual Orexin Antagonism and Emotion and Affective Processing Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Dual Orexin Antagonism and Emotion and Affective Processing Study — Stella

Recruiting

Back to Learning trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United Kingdom

Department of Psychiatry, University of Oxford, Oxford

Key details

Phase

Post-approval study

Sponsor

University of Oxford

Enrollment target

~62 participants

Started

October 2025

Primary completion

September 2026

Age range

18 Years – 40 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov